 Amanda Piquet
Concepts (152)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Encephalitis | 7 | 2023 | 134 | 4.090 |
Why?
| | Meningitis | 4 | 2023 | 81 | 2.020 |
Why?
| | Stiff-Person Syndrome | 3 | 2024 | 12 | 2.000 |
Why?
| | Glial Fibrillary Acidic Protein | 3 | 2024 | 93 | 1.770 |
Why?
| | Meningoencephalitis | 2 | 2021 | 25 | 1.410 |
Why?
| | Hashimoto Disease | 2 | 2020 | 11 | 1.340 |
Why?
| | Autoantibodies | 9 | 2024 | 1464 | 1.170 |
Why?
| | Autoimmune Diseases of the Nervous System | 2 | 2023 | 24 | 1.020 |
Why?
| | Lupus Vasculitis, Central Nervous System | 1 | 2024 | 15 | 0.920 |
Why?
| | Neurofilament Proteins | 1 | 2024 | 44 | 0.900 |
Why?
| | Nervous System Diseases | 3 | 2023 | 260 | 0.820 |
Why?
| | Enterovirus A, Human | 1 | 2021 | 12 | 0.740 |
Why?
| | Rituximab | 1 | 2021 | 162 | 0.690 |
Why?
| | Central Nervous System Viral Diseases | 1 | 2021 | 73 | 0.680 |
Why?
| | Interferon-gamma | 1 | 2023 | 759 | 0.680 |
Why?
| | Myelitis | 1 | 2021 | 99 | 0.670 |
Why?
| | Neuromuscular Diseases | 1 | 2021 | 106 | 0.660 |
Why?
| | Paraneoplastic Syndromes, Nervous System | 3 | 2024 | 12 | 0.640 |
Why?
| | Immunologic Factors | 1 | 2021 | 227 | 0.640 |
Why?
| | Oxidoreductases | 1 | 2019 | 91 | 0.620 |
Why?
| | Enterovirus Infections | 1 | 2021 | 171 | 0.610 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2024 | 576 | 0.600 |
Why?
| | Nerve Tissue Proteins | 4 | 2024 | 570 | 0.590 |
Why?
| | Autoimmune Diseases | 2 | 2018 | 421 | 0.560 |
Why?
| | Immunoglobulin G | 2 | 2023 | 837 | 0.520 |
Why?
| | Autoimmunity | 2 | 2018 | 861 | 0.500 |
Why?
| | T-Lymphocytes | 1 | 2023 | 1913 | 0.480 |
Why?
| | Biomarkers | 3 | 2024 | 3878 | 0.460 |
Why?
| | Nuclear Proteins | 1 | 2019 | 644 | 0.460 |
Why?
| | Multiple Sclerosis | 3 | 2024 | 428 | 0.450 |
Why?
| | Dopaminergic Neurons | 2 | 2015 | 55 | 0.410 |
Why?
| | Brain Tissue Transplantation | 1 | 2012 | 19 | 0.400 |
Why?
| | Parkinson Disease | 2 | 2019 | 410 | 0.380 |
Why?
| | Humans | 32 | 2024 | 129079 | 0.350 |
Why?
| | Breast Neoplasms | 1 | 2022 | 2116 | 0.340 |
Why?
| | Flavivirus Infections | 2 | 2019 | 9 | 0.330 |
Why?
| | Middle Aged | 10 | 2024 | 31024 | 0.280 |
Why?
| | Receptors, Glycine | 1 | 2024 | 4 | 0.230 |
Why?
| | Aquaporin 4 | 1 | 2024 | 95 | 0.220 |
Why?
| | Paraneoplastic Cerebellar Degeneration | 1 | 2023 | 1 | 0.220 |
Why?
| | Young Adult | 4 | 2024 | 12310 | 0.220 |
Why?
| | Male | 14 | 2024 | 63248 | 0.220 |
Why?
| | Medical Tourism | 1 | 2023 | 9 | 0.220 |
Why?
| | Adult | 8 | 2024 | 35423 | 0.210 |
Why?
| | Neuroglia | 1 | 2024 | 166 | 0.210 |
Why?
| | Neuromyelitis Optica | 1 | 2024 | 127 | 0.210 |
Why?
| | Flavivirus | 2 | 2019 | 17 | 0.210 |
Why?
| | Transplantation, Autologous | 1 | 2024 | 214 | 0.210 |
Why?
| | Encephalomyelitis | 1 | 2022 | 9 | 0.200 |
Why?
| | Antibodies, Viral | 2 | 2024 | 599 | 0.200 |
Why?
| | Multicenter Studies as Topic | 1 | 2024 | 288 | 0.200 |
Why?
| | Neurology | 1 | 2024 | 103 | 0.200 |
Why?
| | Female | 11 | 2024 | 68274 | 0.200 |
Why?
| | Exanthema | 1 | 2022 | 76 | 0.190 |
Why?
| | Antibodies, Monoclonal, Humanized | 2 | 2024 | 750 | 0.190 |
Why?
| | Astrocytes | 1 | 2023 | 190 | 0.190 |
Why?
| | Mycobacterium abscessus | 1 | 2023 | 110 | 0.190 |
Why?
| | Antigens, Neoplasm | 1 | 2024 | 309 | 0.180 |
Why?
| | Prevalence | 2 | 2024 | 2541 | 0.180 |
Why?
| | Incidence | 2 | 2024 | 2635 | 0.180 |
Why?
| | Receptors, AMPA | 1 | 2022 | 134 | 0.180 |
Why?
| | Eosinophils | 1 | 2023 | 324 | 0.180 |
Why?
| | Education, Medical | 1 | 2024 | 241 | 0.180 |
Why?
| | Emergencies | 1 | 2022 | 164 | 0.180 |
Why?
| | Lupus Erythematosus, Systemic | 1 | 2023 | 251 | 0.180 |
Why?
| | Aged | 5 | 2024 | 22068 | 0.170 |
Why?
| | Piperazines | 1 | 2022 | 326 | 0.170 |
Why?
| | Encephalomyelitis, Eastern Equine | 1 | 2019 | 5 | 0.170 |
Why?
| | Bunyaviridae Infections | 1 | 2019 | 8 | 0.170 |
Why?
| | Encephalitis, California | 1 | 2019 | 11 | 0.160 |
Why?
| | Encephalitis, Tick-Borne | 1 | 2019 | 8 | 0.160 |
Why?
| | Sexual and Gender Minorities | 1 | 2022 | 158 | 0.160 |
Why?
| | Arbovirus Infections | 1 | 2019 | 18 | 0.160 |
Why?
| | Neoplasms | 2 | 2024 | 2429 | 0.160 |
Why?
| | Clinical Trials as Topic | 1 | 2024 | 1005 | 0.160 |
Why?
| | Glutamate Decarboxylase | 1 | 2019 | 166 | 0.160 |
Why?
| | Cognitive Dysfunction | 1 | 2023 | 333 | 0.160 |
Why?
| | Pyridines | 1 | 2022 | 472 | 0.150 |
Why?
| | Syndrome | 1 | 2019 | 343 | 0.150 |
Why?
| | Spinal Cord Diseases | 1 | 2018 | 40 | 0.150 |
Why?
| | Antineoplastic Agents, Immunological | 1 | 2020 | 170 | 0.150 |
Why?
| | B-Lymphocytes | 1 | 2023 | 813 | 0.150 |
Why?
| | Mycobacterium Infections, Nontuberculous | 1 | 2023 | 376 | 0.150 |
Why?
| | Adolescent | 5 | 2024 | 20241 | 0.140 |
Why?
| | Lyme Neuroborreliosis | 1 | 2017 | 2 | 0.140 |
Why?
| | Colorado | 2 | 2024 | 4446 | 0.140 |
Why?
| | Case-Control Studies | 1 | 2024 | 3336 | 0.130 |
Why?
| | Paralysis | 1 | 2017 | 71 | 0.130 |
Why?
| | Central Nervous System Infections | 1 | 2016 | 36 | 0.130 |
Why?
| | Neurons | 1 | 2024 | 1437 | 0.130 |
Why?
| | Retinal Pigment Epithelium | 1 | 2015 | 68 | 0.120 |
Why?
| | Retrospective Studies | 4 | 2024 | 14562 | 0.120 |
Why?
| | Cocaine-Related Disorders | 1 | 2015 | 108 | 0.110 |
Why?
| | Proteins | 1 | 2018 | 945 | 0.100 |
Why?
| | Membrane Proteins | 1 | 2018 | 1102 | 0.100 |
Why?
| | Diagnosis, Differential | 1 | 2016 | 1435 | 0.100 |
Why?
| | Child | 3 | 2024 | 20860 | 0.080 |
Why?
| | Prospective Studies | 1 | 2019 | 7070 | 0.070 |
Why?
| | Substance-Related Disorders | 1 | 2015 | 1022 | 0.070 |
Why?
| | Magnetic Resonance Imaging | 1 | 2016 | 3357 | 0.060 |
Why?
| | Animals | 5 | 2024 | 34708 | 0.060 |
Why?
| | Capsid | 1 | 2024 | 89 | 0.050 |
Why?
| | Immunity, Humoral | 1 | 2024 | 118 | 0.050 |
Why?
| | District of Columbia | 1 | 2022 | 26 | 0.050 |
Why?
| | Monkeypox virus | 1 | 2022 | 13 | 0.050 |
Why?
| | Immunity, Cellular | 1 | 2024 | 267 | 0.050 |
Why?
| | Limbic Encephalitis | 1 | 2021 | 4 | 0.050 |
Why?
| | Infusions, Intravenous | 1 | 2023 | 395 | 0.050 |
Why?
| | Patient Outcome Assessment | 1 | 2023 | 128 | 0.050 |
Why?
| | Antibodies, Neutralizing | 1 | 2024 | 258 | 0.050 |
Why?
| | Epitopes | 1 | 2024 | 469 | 0.050 |
Why?
| | Homosexuality, Male | 1 | 2022 | 172 | 0.050 |
Why?
| | Neuroimaging | 1 | 2023 | 275 | 0.050 |
Why?
| | RNA, Viral | 1 | 2024 | 622 | 0.040 |
Why?
| | Bunyamwera virus | 1 | 2019 | 3 | 0.040 |
Why?
| | Encephalitis Virus, California | 1 | 2019 | 6 | 0.040 |
Why?
| | Inpatients | 1 | 2024 | 456 | 0.040 |
Why?
| | Stem Cells | 1 | 2023 | 573 | 0.040 |
Why?
| | North America | 1 | 2019 | 289 | 0.040 |
Why?
| | Acute Disease | 1 | 2022 | 978 | 0.040 |
Why?
| | Potassium Channels, Voltage-Gated | 1 | 2018 | 49 | 0.040 |
Why?
| | Communication | 1 | 2024 | 839 | 0.040 |
Why?
| | Borrelia burgdorferi Group | 1 | 2017 | 9 | 0.040 |
Why?
| | Longitudinal Studies | 1 | 2024 | 2670 | 0.030 |
Why?
| | United States | 2 | 2024 | 13992 | 0.030 |
Why?
| | RNA, Messenger | 1 | 2024 | 2702 | 0.030 |
Why?
| | Antibodies, Bacterial | 1 | 2017 | 138 | 0.030 |
Why?
| | Retinal Pigments | 1 | 2015 | 5 | 0.030 |
Why?
| | Drug-Seeking Behavior | 1 | 2015 | 22 | 0.030 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2018 | 422 | 0.030 |
Why?
| | Vaccination | 1 | 2024 | 1351 | 0.030 |
Why?
| | Self Administration | 1 | 2015 | 126 | 0.030 |
Why?
| | Conditioning, Operant | 1 | 2015 | 103 | 0.030 |
Why?
| | Ventral Tegmental Area | 1 | 2015 | 50 | 0.030 |
Why?
| | Extinction, Psychological | 1 | 2015 | 84 | 0.030 |
Why?
| | Spinal Cord | 1 | 2017 | 360 | 0.030 |
Why?
| | Nucleus Accumbens | 1 | 2015 | 128 | 0.030 |
Why?
| | Immunotherapy | 1 | 2018 | 584 | 0.030 |
Why?
| | Cocaine | 1 | 2015 | 150 | 0.030 |
Why?
| | Prognosis | 1 | 2022 | 3793 | 0.030 |
Why?
| | Reward | 1 | 2015 | 238 | 0.030 |
Why?
| | Dopamine | 1 | 2015 | 281 | 0.030 |
Why?
| | Prefrontal Cortex | 1 | 2015 | 295 | 0.030 |
Why?
| | Emergency Service, Hospital | 1 | 2022 | 1978 | 0.020 |
Why?
| | Rats, Sprague-Dawley | 1 | 2015 | 2311 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2021 | 7063 | 0.020 |
Why?
| | Epithelial Cells | 1 | 2015 | 1063 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2022 | 10256 | 0.020 |
Why?
| | Rats | 1 | 2015 | 5254 | 0.020 |
Why?
| | Mice | 1 | 2024 | 16583 | 0.020 |
Why?
| | Anti-Bacterial Agents | 1 | 2017 | 1702 | 0.020 |
Why?
| | Child, Preschool | 1 | 2018 | 10462 | 0.010 |
Why?
|
|
Piquet's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|